Switch theme
Sign up to access all valuation multiples
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation’s limited range. The company derives maximum revenue from Israel.
2015
125
Last FY Revenue n/a
LTM EBITDA -$38.7M
$212M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Alpha Tau Medical has a last 12-month revenue (LTM) of n/a and a last 12-month EBITDA of -$38.7M.
In the most recent fiscal year, Alpha Tau Medical achieved revenue of n/a and an EBITDA of -$30.3M.
Alpha Tau Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Alpha Tau Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | n/a | XXX | n/a | XXX | XXX | XXX |
| Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA | -$38.7M | XXX | -$30.3M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBIT | -$38.1M | XXX | -$36.0M | XXX | XXX | XXX |
| EBIT Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| Net Profit | -$34.0M | XXX | -$31.8M | XXX | XXX | XXX |
| Net Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Alpha Tau Medical's stock price is $3.
Alpha Tau Medical has current market cap of $252M, and EV of $212M.
See Alpha Tau Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $212M | $252M | XXX | XXX | XXX | XXX | $-0.46 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Alpha Tau Medical has market cap of $252M and EV of $212M.
Alpha Tau Medical's trades at n/a EV/Revenue multiple, and -7.0x EV/EBITDA.
Equity research analysts estimate Alpha Tau Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Alpha Tau Medical has a P/E ratio of -7.4x.
See valuation multiples for Alpha Tau Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $252M | XXX | $252M | XXX | XXX | XXX |
| EV (current) | $212M | XXX | $212M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | n/a | XXX | XXX | XXX |
| EV/EBITDA | -5.5x | XXX | -7.0x | XXX | XXX | XXX |
| EV/EBIT | -5.6x | XXX | -5.9x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | -7.4x | XXX | -7.9x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -9.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAlpha Tau Medical's revenue per employee in the last FY averaged n/a, while opex per employee averaged $0.3M for the same period.
Alpha Tau Medical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Alpha Tau Medical's rule of X is n/a (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Alpha Tau Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | -19% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Alpha Tau Medical acquired XXX companies to date.
Last acquisition by Alpha Tau Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Alpha Tau Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Alpha Tau Medical founded? | Alpha Tau Medical was founded in 2015. |
| Where is Alpha Tau Medical headquartered? | Alpha Tau Medical is headquartered in United States of America. |
| How many employees does Alpha Tau Medical have? | As of today, Alpha Tau Medical has 125 employees. |
| Who is the CEO of Alpha Tau Medical? | Alpha Tau Medical's CEO is Mr. Uzi Sofer. |
| Is Alpha Tau Medical publicy listed? | Yes, Alpha Tau Medical is a public company listed on NAS. |
| What is the stock symbol of Alpha Tau Medical? | Alpha Tau Medical trades under DRTS ticker. |
| When did Alpha Tau Medical go public? | Alpha Tau Medical went public in 2022. |
| Who are competitors of Alpha Tau Medical? | Similar companies to Alpha Tau Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Alpha Tau Medical? | Alpha Tau Medical's current market cap is $252M |
| Is Alpha Tau Medical profitable? | Yes, Alpha Tau Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Alpha Tau Medical? | Alpha Tau Medical's last 12 months EBITDA is -$38.7M. |
| What is the current EV/EBITDA multiple of Alpha Tau Medical? | Current EBITDA multiple of Alpha Tau Medical is -5.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
